spacer
home > ebr > autumn 2019 > trial by fire
PUBLICATIONS
European Biopharmaceutical Review

Trial by Fire




Cannabis policy change is sweeping across the globe. One by one, countries, states, and territories are turning back a century of cannabis prohibition, at times led by a chorus of voters, outraged patient groups, or sometimes championed by only a single mother.

Cannabis is not a therapeutic drug born in the usual way. It is not a molecule designed, conceived, or synthesised and then selected by chance from a library of designer candidate compounds. It was not discovered by accident by an observant scientist. Cannabis sativa is, in fact, not one thing at all, but the botanical factory of a chemical symphony that has evolved alongside humans for over millennia (1).

For a long time, we understood this and simply harnessed its abilities. Nicholas Culpeper wrote of hemp in his book from 1649, later known as The Complete Herbal, which read that it is "so well known… I shall not need to write any description of it” (2). Whether or not “…the juice dropped into the ears kills worms in them”, as he so colourfully describes, is, of course, subject to interpretation.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Mark A Ware is currently the Chief Medical Officer at Canopy Growth Corporation. He has taken a leave of absence as Associate Professor in Family Medicine and Anesthesia at McGill University, Canada, from July 2018 to work in this capacity. His research has been funded and supported by the Canadian Institutes of Health Research, FRQS, private foundations, and pharma companies. He has published over 100 papers on cannabis and pain research in academic journals, written six book chapters, and given hundreds of lectures to health professionals and the public on cannabis over the last 20 years. He served as a consultant to several large corporate and academic research programmes internationally and has advised the Canadian Federal Government on cannabis policy since 2001 and 2016, serving as the Vice Chair of the Federal Task Force on the legalisation and regulation of cannabis in Canada.
spacer
Dr Mark A Ware
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.
More info >>

White Papers
 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement